weight-loss drugs

Samsung Electronics Co. reaffirmed the recovery in the global chip market in the latter half of this year after confirming a downward trend in memor...

Samsung Electronics Co. on Wednesday unveiled the newest edition to its Galaxy Z foldable series – Galaxy Z Flip 5 and Fold 5 – designed...

GS Engineering & Construction Co., South Korea’s major construction firm, posted a quarterly operating loss in the April-June period for t...

South Korea’s Vestas Investment Management Co. is slated to sell off a London-based office tower as the property value has plunged due to rate...

SK Hynix Inc. reported an operating loss in the second quarter of this year, extending its losing streak to three consecutive quarters and inflating...

South Korean pharmaceutical company Kwangdong Pharmaceutical announced on Monday that it signed an agreement for securing exclusive sales and distri...

SK Chemicals Co., a South Korean chemicals maker and drug developer, said on Thursday it has signed a contract to supply diabetes medications to glo...

South Korea’s SK Biopharmaceuticals Co. is aiming to triple its enterprise value to $15 billion by 2026 with the goal of rising to the top run...

Prestige Biopharma, a Singapore-based biopharmaceutical company with operations in South Korea and the US, announced on Tuesday that it will partici...

South Korea's SK Biopharmaceuticals has received approval in Canada to sell its new epilepsy drug Cenobamate under the product name Xcopri. Having e...

Employment in South Korea extended its growth streak in June but its gains slowed for the third straight month, with youth jobs declining for eight ...

Shares of EcoPro Co., a South Korean battery materials maker, have skyrocketed this year, rising 848% year to date to break above the 1 million won ...

Samsung Biologics Co., the world’s top contract manufacturing organization by capacity, inked a $391 million contract from Novartis, nearly fi...

South Korean bio-health company HK inno.N Corporation's new drug for gastroesophageal reflux disease (GERD) K-CAB has been officially launched in In...

South Korea’s stem cell tech company SCM Lifescience on Wednesday said it has started full-scale exports to Southeast Asia of its hair loss ca...

South Korea’s National Pension Service (NPS) has logged an 8.63% profit in fund management in January-April this year thanks to strong equity ...

South Korean pharmaceutical firm LegoChem Biosciences Inc. announced on Thursday that it has received approval from the US Food and Drug Administrat...

South Korean artificial intelligence (AI) drugmaker Syntekabio Inc. has partnered up with a US clinical research organization (CRO) to enter the wor...

South Korea's SK Chemicals has joined forces with global pharmaceutical firm AstraZeneca to initiate commercial production of a chemical drug for di...

South Korea’s leading chemicals company LG Chem Ltd. is slated to secure about 2 trillion won ($1.6 billion) by selling a minority stake in it...

South Korean pharmaceutical firm, Huons Co., announced on Monday that it has secured another significant regulatory milestone in the US with the Foo...

Merck, known as MSD outside the United States and Canada, announced on Monday that Efinopegdutide, a technology transferred from the South Korean ph...

South Korea's first-generation biopharma venture company CrystalGenomics Inc. on Wednesday said it received a $2 million (2.6 billion won) order fro...

 Among the most cited stock market sayings by experts and laymen alike are “buy the dips” or “sell on news” – tim...

South Korea is poised to boost the biotech industry by accelerating research, education and business partnerships with the biopharmaceutical sector ...

National Pension Service (NPS) in South Korea achieved a 6.4% return on investment during the first quarter of this year, recovering some 73% of the...

It's time again to snap up semiconductor stocks – the market darlings these days.Just like its global peers, including the New York Stock Exch...

South Korean biosimilar giant Celltrion Inc. revealed on Wednesday the highly anticipated clinical phase 1 data for its Actemra biosimilar, CT-P47, ...

Major South Korean e-commerce companies’ deficits have mounted to a level near their combined funds raised from investors, stoking fears that ...

A private fund for US real estate managed by South Korea’s Mirae Asset Global Investments Co. has seen huge losses amid the tumble of the offi...